EcoDrugPlus

Histone Deacetylase 4

Ensembl ID : ENSPFOG00000001958
Gene Symbol: HDAC4
3 Cross references
202 Possible Orthologues:

Histone Deacetylase 5

Ensembl ID : ENSPFOG00000016912
Gene Symbol: HDAC5
1 Cross references
193 Possible Orthologues:

Histone Deacetylase 6

Ensembl ID : ENSPFOG00000001762
Gene Symbol: HDAC6
1 Cross references
180 Possible Orthologues:

Histone Deacetylase 7

Ensembl ID : ENSPFOG00000017391
Gene Symbol: HDAC7
3 Cross references
189 Possible Orthologues:

Histone Deacetylase 7-Like

Ensembl ID : ENSPFOG00000001452
Gene Symbol: LOC103139515
2 Cross references
195 Possible Orthologues:

Histone Deacetylase 8

Ensembl ID : ENSPFOG00000020106
Gene Symbol: HDAC8
1 Cross references
205 Possible Orthologues:

Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 4

Ensembl ID : ENSPFOG00000001438
Gene Symbol: HCN4
1 Cross references
221 Possible Orthologues:

Hypocretin (Orexin) Receptor 2

Ensembl ID : ENSPFOG00000009773
Gene Symbol: HCRTR2
1 Cross references
203 Possible Orthologues:

Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1 Homolog

Ensembl ID : ENSPFOG00000002083
Gene Symbol: LOC103129193
3 Cross references
211 Possible Orthologues:

Inhibitor Of Nuclear Factor Kappa B Kinase Subunit Beta

Ensembl ID : ENSPFOG00000012837
Gene Symbol: IKBKB
3 Cross references
199 Possible Orthologues:

Inositol Polyphosphate-5-Phosphatase D

Ensembl ID : ENSPFOG00000021881
Gene Symbol: INPP5D
3 Cross references
215 Possible Orthologues:

Insulin Receptor

Ensembl ID : ENSPFOG00000003462
Gene Symbol: INSR
3 Cross references
213 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).